Legal Representation
Attorney
Simone Chen
USPTO Deadlines
Application History
13 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 14, 2025 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED | Loading... |
| Jul 15, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jul 15, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 9, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 11, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 11, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jun 11, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jun 11, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jun 11, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jun 5, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 28, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 28, 2025 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Dec 19, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of cancer, solid tumor cancer, blood tumor cancer, autoimmune disease, infectious disease, genetic defect disease; medicines for human purposes, namely, medicinal preparations for the treatment of cancer, solid tumor cancer, blood tumor cancer, autoimmune disease, infectious disease, genetic defect disease; pharmaceutical preparations for prevention and treatment and health maintenance of cancer, solid tumor cancer, blood tumor cancer, autoimmune disease, infectious disease, genetic defect disease; chemical preparations for medical purposes, namely, for disease prevention and treatment and health maintenance of cancer, solid tumor cancer, blood tumor cancer, autoimmune disease, infectious disease, genetic defect disease; biological preparations for medical purposes for the treatment of cancer, solid tumor cancer, blood tumor cancer, autoimmune disease, infectious disease, genetic defect disease; immunostimulants; radioactive substances for medical purposes; chemico-pharmaceutical preparations; vaccines; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic preparations for medical purposes used by medical laboratories; chemical preparations for pharmaceutical purposes, namely, for disease prevention and treatment and health maintenance of cancer, solid tumor cancer, blood tumor cancer, autoimmune disease, infectious disease, genetic defect disease
Class 042
Chemical research; chemical analysis; research and development services in the field of chemistry; biological research; bacteriological research; scientific research in the nature of conducting clinical trials for others; medical research; scientific research in the field of genetics; consulting services in the field of pharmaceutical research and development; research and development of new products for third parties in the scientific and medical field; research and development of new products for others; technological research in the field of pharmaceutical studies; conducting scientific study and research in the fields of medicine, prevention, treatment and management of illness, health care delivery, disease detection and treatment; technical writing; scientific laboratory services; scientific research; technological consultancy in the field of pharmaceuticals; culturing of cells for others for scientific research purposes; laboratory services for biomanufacturing.
Additional Information
Design Mark
The mark consists of the stylized wording "CO" and "NECTAR" where the letter "O" comprises a circular shape at the center and two additional circular shapes stem off of it extending to the right. Between the letters "O" and "N" are two stacked square shapes.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
042